A Q4 2022 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q4 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.8B+11.4% YoY

Gross Profit

$1.0B54.7% margin

Operating Income

$471M25.5% margin

Net Income

$368M19.9% margin

EPS (Diluted)

$1.23

QoQ Revenue Growth

+7.6%

Cash Flow

Operating Cash Flow

$448M

Free Cash Flow

$378M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$10.5B

Total Liabilities

$5.2B

Stockholders' Equity

$5.3B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.8B	$1.7B	+11.4%
Gross Profit	$1.0B	$900M	+12.4%
Operating Income	$471M	$395M	+19.2%
Net Income	$368M	$442M	-16.7%

Revenue Segments

Life Sciences and Applied Markets

$1.1B60%

Agilent CrossLab

$381M21%

Diagnostics and Genomics

$352M19%

Geographic Segments

Asia Pacific

$716M39%

Americas

$715M39%

Europe

$418M23%